RxSight (RXST) Cash from Operations Growth (1y) (2021 - 2026)
Powered by 
Analysis
RxSight (RXST) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -12.60% |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -117.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -117.96% |
| Mar 31, 2026 | -23.31% |
| Dec 31, 2025 | 73.80% |
| Sep 30, 2025 | -282.62% |
| Jun 30, 2025 | -8.67% |
| Mar 31, 2025 | 5.12% |
| Dec 31, 2024 | 48.68% |
| Sep 30, 2024 | 108.14% |
| Jun 30, 2024 | 46.63% |
| Mar 31, 2024 | 47.60% |
| Dec 31, 2023 | 40.08% |
| Sep 30, 2023 | 47.45% |
| Jun 30, 2023 | 49.09% |
| Mar 31, 2023 | -18.55% |
| Dec 31, 2022 | -58.84% |
| Sep 30, 2022 | -10.42% |
| Jun 30, 2022 | -23.74% |
| Mar 31, 2022 | -46.17% |
| Dec 31, 2021 | -6.02% |
| Sep 30, 2021 | -97.97% |